Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytochrome P450 family 51 subfamily A member 1 pseudogene 2 (CYP51A1P2) is a presumed non-functional copy of the gene encoding lanosterol 14α-demethylase, an enzyme involved in sterol biosynthesis[5]. Pseudogenes like CYP51A1P2 generally arise by gene duplication and subsequent disabling mutations, and do not produce functional protein. No literature demonstrates any biological, clinical, or pharmaceutical relevance for CYP51A1P2, nor the existence of any validated aliases, functional roles, drug interactions, mechanisms of action, disease roles, biomarker use, or safety considerations.
None.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytochrome P450 family 51 subfamily A member 1 pseudogene 2 (CYP51A1P2).